We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Corgenix Announces Diagnostic Development Agreement with Lilly

News   May 23, 2013

 
Corgenix Announces Diagnostic Development Agreement with Lilly
 
 
 

RELATED ARTICLES

Post-heart Attack Antibody Levels May Guide Treatment

News

Levels of antiphospholipid antibodies, which are associated with rheumatic diseases, are also elevated in myocardial infarction without any autoimmune co-morbidity.

READ MORE

Cellular Dumpster-diving Enables Degradation Landscape Exploration

News

A novel technology for profiling protein turnover and degradation offers new insight into diagnosis and understanding the molecular basis of autoimmunity, cancer, neurodegeneration and other disorders.

READ MORE

Test Which Identifies Drug-resistant Tuberculosis Bacteria Now Available In Europe

News

Now available in Europe: A diagnostic test which can simultaneously detect tuberculosis-causing bacteria and determine if the bacteria contain mutations associated with resistance to two important first line drugs.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE